Practice of pharmacy; designating certain drugs as over-the-counter; prohibiting pharmacist or pharmacy from requiring prescription; providing penalties. Effective date.
SB 426 designates chloroquine, hydroxychloroquine, and ivermectin as over-the-counter drugs in Oklahoma, requiring pharmacists and pharmacies to sell these medications without prescriptions. The bill directly affects pharmacists and pharmacies, prohibiting them from demanding prescriptions for these specific drugs. Violations carry severe penalties: license revocation and a $100,000 fine per occurrence, enforced by the State Board of Pharmacy. This law creates a concrete policy change by removing prescription barriers for these three medications at the point of sale.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2025
Committee Review
Floor Vote
Governor
Introduced Feb 3, 2025
Last action Feb 20, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
4
Key actions
0
Committee
0
Feb 3, 2025
Introduced
First Reading
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Shane Jett
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 426
Scope: OK
Hi! I can help you understand SB 426. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline